Drug and Driving: A Compendium of Research Studies
Annotated Sources (cont'd)
France
40. Marquet, P., Delpla, P, Kerguelen, S., Bremond, J., Facy, F., Garnier, M., Guery, B., Lhermitte, M., Mathe, D., Pelissier, A., Renaudeau, C., Vest, and P., Seguela, J. (1998)
Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: A collaborative study. Journal of Forensic Sciences 43(4): 806-811.
Overview
Case-control study of patients reporting to ER in France
Type of study, population(s) and proportion tested
296 drivers of any motorized vehicle (18-35 years old) recruited in emergency rooms, regardless of severity of injury (in France)
Comparative group made up of 278 patients (18-35 years old) admitted during the same time for non-traumatic reasons
Case-control study
Time period not mentioned
Drugs examined (threshold values for detection)
- Cannabinoids (50 ng/ml)
- Opiates (40 ng/ml)
- Cocaine and metabolites (50 ng/ml)
- Amphetamines (200 ng/ml)
Method of testing and medium used
Urine sample
Other dependent variables
Findings (including statistical methods)
Stepwise logistic regression
In general, no significant differences between drivers and patients in cannabis prevalence (14% versus 8%, p=0.054)
Among drivers, users tended to be male (twice as many)
This difference was significant when looking at females only (adjusted for age) (8% for drivers versus 2% for patients)
Significantly higher prevalence of cannabinoids in male than in female drivers (16% versus 8%) as well as in patients (12% versus 2%)
In general, no significant differences between drivers and patients in opiate prevalence (11% versus 10%)
When looking at those who were positive for both cannabinoids and opiates, both male drivers and male patients had a significantly higher prevalence of opiates than negative-cannabinoid drivers and patients
- Date modified: